Giorgia Jurisic Snijder

Company: CSL R&D

Job title: Head of Cellular Pharmacology & Imaging Zurich

Seminars:

Panel Discussion | Sharing Learnings from Successful Model Systems Used to Demonstrate Efficacy of Treatment in CKD & Accelerate Progression to the Clinic 1:30 pm

Ensuring confidence of in vivo or in vitro kidney tissue to behave like in the human condition Assessing the suitability of different models for testing specific targets Despite successes, outlining key aspects of preclinical model development in CKD that require further refinement to enhance translational capabilitiesRead more

day: Day 2 Track 1 PM

Repositioning AKI at the Forefront of R&D: Targeting Complex Pathophysiology, Overcoming Heterogeneity & Enhancing Return on Investment 11:00 am

The heterogeneity across phenotypic subtypes has made AKI significantly difficult to study, therefore making progress of new specific treatments and disease management rather stagnant in recent years. From balancing the need for AKI resolution while minimizing long-term kidney damage, to addressing AKI subtypes with medical interventions that target specific underlying causes, tackle key questions with…Read more

day: Pre-Conference Workshop Day